Artwork

Content provided by Richard Jacobs. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Richard Jacobs or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Revolutionizing Healthcare: How Bioengineering & Stem Cells Are Transforming The Future Of Medicine

27:56
 
Share
 

Manage episode 493145158 series 1538640
Content provided by Richard Jacobs. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Richard Jacobs or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Can bioengineering improve the health, vitality, and longevity of human beings? What would the future look like if the medical system were about preserving health rather than just treating symptoms? In this episode, Kevin Caldwell, the CEO, Co-Founder, and President of Ossium Health, sits down to share his thoughts…

Ossium Health is a commercial-stage bioengineering company that uses its exclusive organ donor bone marrow banking platform to develop stem cell therapies for patients suffering from life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal defects. Initially built from a small startup, it evolved into the clinical-stage bioengineering company it is today with one primary mission: To improve human health through bioengineering.

Join the conversation now to explore:

● How Kevin’s mindset shift in business led to the creation of Ossium.

● Why the healthcare system isn’t adequately equipped to deal with modern chronic diseases.

● Types of cell therapies that provide relief for patients with blood and immune conditions.

● The role that cell composition plays in the reactivity between donors and recipients.

Before founding Ossium, Kevin worked as an Engagement Manager at McKinsey’s San Francisco office, where he advised clients in the biotechnology and healthcare industries. His projects spanned from conducting due diligence on biotech startup acquisitions to restructuring financially distressed biopharma companies.

Over the course of his tenure, Kevin led more than 20 engagements for over a dozen clients, guiding teams in strategies for revenue growth, market-entry, and organizational restructuring.

To learn about Kevin’s cutting-edge work with Ossium Health, visit their website now!

🎧 Listen now on Apple Podcasts: http://apple.co/30PvU9C

  continue reading

4144 episodes

Artwork
iconShare
 
Manage episode 493145158 series 1538640
Content provided by Richard Jacobs. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Richard Jacobs or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Can bioengineering improve the health, vitality, and longevity of human beings? What would the future look like if the medical system were about preserving health rather than just treating symptoms? In this episode, Kevin Caldwell, the CEO, Co-Founder, and President of Ossium Health, sits down to share his thoughts…

Ossium Health is a commercial-stage bioengineering company that uses its exclusive organ donor bone marrow banking platform to develop stem cell therapies for patients suffering from life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal defects. Initially built from a small startup, it evolved into the clinical-stage bioengineering company it is today with one primary mission: To improve human health through bioengineering.

Join the conversation now to explore:

● How Kevin’s mindset shift in business led to the creation of Ossium.

● Why the healthcare system isn’t adequately equipped to deal with modern chronic diseases.

● Types of cell therapies that provide relief for patients with blood and immune conditions.

● The role that cell composition plays in the reactivity between donors and recipients.

Before founding Ossium, Kevin worked as an Engagement Manager at McKinsey’s San Francisco office, where he advised clients in the biotechnology and healthcare industries. His projects spanned from conducting due diligence on biotech startup acquisitions to restructuring financially distressed biopharma companies.

Over the course of his tenure, Kevin led more than 20 engagements for over a dozen clients, guiding teams in strategies for revenue growth, market-entry, and organizational restructuring.

To learn about Kevin’s cutting-edge work with Ossium Health, visit their website now!

🎧 Listen now on Apple Podcasts: http://apple.co/30PvU9C

  continue reading

4144 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play